As T cell infusion emerges as a promising avenue for battling lymphoma in dogs, the path forward remains shrouded in uncertainty. Delve into the realm of veterinary oncology, where questions abound: Which cells hold the key—B or T? What size is the tipping point for success? And when is the optimal moment for intervention?
watch more of the episode on our youtube channel